Advanced search
Publication Cover
International Reviews of Immunology Volume 35, 2016 - Issue 4
Submit an article Journal homepage
1,141
Views
10
CrossRef citations to date
0
Altmetric
Reviews

The Duality of Fgl2 - Secreted Immune Checkpoint Regulator Versus Membrane-Associated Procoagulant: Therapeutic Potential and Implications

Jiemiao HuDepartment of Pediatrics–Research, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
,
Jun YanDepartment of Pediatrics–Research, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
,
Ganesh RaoDepartment of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
,
Khatri LathaDepartment of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
,
Willem W. OverwijkDepartment of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
,
Amy B. HeimbergerDepartment of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
&
Shulin LiDepartment of Pediatrics–Research, The University of Texas MD Anderson Cancer Center, Houston, TX, USACorrespondence[email protected]
 show all
Pages 325-339 | Accepted 17 Aug 2014, Published online: 26 Sep 2014

Citations (10)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Yaoyao Du, Lan Rong, Yuanhua Cong, Lan Shen, Ning Zhang & Bing Wang. (2021) Macrophage polarization: an effective approach to targeted therapy of inflammatory bowel disease. Expert Opinion on Therapeutic Targets 25:3, pages 191-209.
Read now

Articles from other publishers (9)

Wenbin Ji, Weiwei Wang, Peiyuan Li, Yanhong Liu, Baotong Zhang & Feng Qi. (2023) sFgl2 gene-modified MSCs regulate the differentiation of CD4+ T cells in the treatment of autoimmune hepatitis. Stem Cell Research & Therapy 14:1.
Crossref
Xiaoyu Ma, Hongtao Zhu, Lidong Cheng, Xin Chen, Kai Shu & Suojun Zhang. (2022) Targeting FGL2 in glioma immunosuppression and malignant progression. Frontiers in Oncology 12.
Crossref
Leila Amini, Jenny Greig, Michael Schmueck-Henneresse, Hans-Dieter Volk, Séverine Bézie, Petra Reinke, Carole Guillonneau, Dimitrios L. Wagner & Ignacio Anegon. (2021) Super-Treg: Toward a New Era of Adoptive Treg Therapy Enabled by Genetic Modifications. Frontiers in Immunology 11.
Crossref
Xin Yuan, Ya Li, An Zhi Zhang, Chen Hao Jiang, Fan Ping Li, Yu Fang Xie, Jiang Fen Li, Wei Hua Liang, Hai Jun Zhang, Chun Xia Liu, Li Juan Pang, Xi Hua Shen, Feng Li & Jian Ming Hu. (2020) Tumor-associated macrophage polarization promotes the progression of esophageal carcinoma. Aging 13:2, pages 2049-2072.
Crossref
Fatemeh Bayati, Mahsa Mohammadi, Maryam Valadi, Saeid Jamshidi, Arron Munggela Foma & Ehsan Sharif-Paghaleh. (2021) The Therapeutic Potential of Regulatory T Cells: Challenges and Opportunities. Frontiers in Immunology 11.
Crossref
Christopher Tay, Yamin Qian & Shimon Sakaguchi. (2020) Hyper-Progressive Disease: The Potential Role and Consequences of T-Regulatory Cells Foiling Anti-PD-1 Cancer Immunotherapy. Cancers 13:1, pages 48.
Crossref
Pascale Robineau-CharetteDavid Grynspan, Samantha J. Benton, Jeremiah Gaudet, Brian J. CoxBarbara C. VanderhydenShannon A. Bainbridge. (2020) Fibrinogen-Like Protein 2-Associated Transcriptional and Histopathological Features of Immunological Preeclampsia. Hypertension 76:3, pages 910-921.
Crossref
Ying Zhu, Jie Zhou, Yi Feng, Liying Chen, Longhui Zhang, Fei Yang, Haoran Zha, Xinxin Wang, Xiao Han, Chi Shu, Yisong Y. Wan, Qi-Jing Li, Bo Guo & Bo Zhu. (2018) Control of Intestinal Inflammation, Colitis-Associated Tumorigenesis, and Macrophage Polarization by Fibrinogen-Like Protein 2. Frontiers in Immunology 9.
Crossref
Ming Tang, Xu Cao, Peng Li, Kun Zhang, You Li, Quan-you Zheng, Gui-qing Li, Jian Chen, Gui-lian Xu & Ke-qin Zhang. (2017) Increased expression of Fibrinogen-Like Protein 2 is associated with poor prognosis in patients with clear cell renal cell carcinoma. Scientific Reports 7:1.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.